Atossa Therapeutics ATOS
NASDAQ ATOS
$2.34 +0.07 (+3.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

Atossa Therapeutics (ATOS) Cash from Discontinued Operations (2015)

Updated

Atossa Therapeutics (ATOS) reported Cash from Discontinued Operations of -$2.91 million for Q4 2015.

Analysis

Atossa Therapeutics (ATOS) Cash from Discontinued Operations (2015) Analysis & Trends

For FY2015, Atossa Therapeutics posted Cash from Discontinued Operations of -$2.63 million.

  • By year, Cash from Discontinued Operations came in at -$2.09 million in FY2014.
  • Per Business Quant data, the three quarters before Q4 2015 came in at $82,891 (Q3 2015), $682,458 (Q2 2015) and -$493,005 (Q1 2015).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.87 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Atossa Therapeutics 23.35 Mn 23.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -2.91 Mn
Sep 30, 2015 82,891.00
Jun 30, 2015 682,458.00
Mar 31, 2015 -493,005.00
API Access

Atossa Therapeutics Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=ATOS&period=max&api_key=YOUR_API_KEY